BioAmber Inc., a leader in renewable materials,recently announced that it has priced an underwritten public offering of 2,600,000 shares of its common stock at a price of $5.00 per share. The gross proceeds to the Company will be $13.0 million. The offering is expected to close on January 22, 2016, subject to customary closing conditions.Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC, is acting as the sole bookrunning manager for the offering. Raymond James & Associates, Inc. is acting as co-manager for the offering.Net proceeds, after underwriting discounts and commissions and other estimated fees and expenses payable by BioAmber will be approximately $11.8 million.
BioAmber intends to use the net proceeds of the offering for working capital and other general corporate purposes.
The securities described above are being offered by BioAmber pursuant to a shelf registration statement on Form S-3 (No. 333-196470) including a base prospectus, which was declared effective by the Securities and Exchange Commission (the “SEC”) on July 9, 2014. The securities may be offered only by means of a prospectus. The prospectus and the preliminary prospectus supplement related to the offering have been filed with the SEC and are available on the SEC’s website located at www.sec.gov and may also be obtained by contacting Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC, at email@example.com. Copies of the final prospectus supplement and the accompanying prospectus relating to the securities being offered, when available, will be available on the SEC’s website and may also be obtained by contacting Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC, at firstname.lastname@example.org.